2-(3,4-Dimethoxyphenyl)-4-(3-pyridinylmethylene)-5(4H)-oxazolone
98%
- Product Code: 245644
CAS:
304000-05-3
| Molecular Weight: | 310.3 g./mol | Molecular Formula: | C₁₇H₁₄N₂O₄ |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | 460.9±55.0 °C(Predicted) | |
| Density: | 1.26±0.1 g/cm3(Predicted) | Storage Condition: | -20°C, Sealed, Dry |
Product Description:
Used in organic synthesis as an intermediate for pharmaceuticals and biologically active compounds. Shows potential in the development of kinase inhibitors due to the presence of pyridinyl and methoxyphenyl groups, which are common in enzyme inhibition. Also employed in research for anticancer agents, where the oxazolone core contributes to cytotoxic activity. Applied in the study of structure-activity relationships for drug design, particularly in heterocyclic chemistry.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 5mg | 10-20 days | ฿9,890.00 |
+
-
|
| 25mg | 10-20 days | ฿28,590.00 |
+
-
|
2-(3,4-Dimethoxyphenyl)-4-(3-pyridinylmethylene)-5(4H)-oxazolone
Used in organic synthesis as an intermediate for pharmaceuticals and biologically active compounds. Shows potential in the development of kinase inhibitors due to the presence of pyridinyl and methoxyphenyl groups, which are common in enzyme inhibition. Also employed in research for anticancer agents, where the oxazolone core contributes to cytotoxic activity. Applied in the study of structure-activity relationships for drug design, particularly in heterocyclic chemistry.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :